ELK1 and colonic neoplasm: Elk-1 positive rates were 92.19% in colon cancer (Table 1; Figures 1(b4), 1(c4), 1(d4), and 1(e4)) and 40.63% in para-carcinoma specimens (Table 1; Figure 1(a4)).